These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35360490)

  • 1. Corrigendum: Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease.
    Serranilla M; Woodin MA
    Front Cell Neurosci; 2022; 16():876821. PubMed ID: 35360490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease.
    Serranilla M; Woodin MA
    Front Cell Neurosci; 2021; 15():817013. PubMed ID: 35095429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.
    Hsu YT; Chang YG; Chang CP; Siew JJ; Chen HM; Tsai CH; Chern Y
    Mov Disord; 2017 Nov; 32(11):1600-1609. PubMed ID: 28782830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Na
    Hsu YT; Chang YG; Liu YC; Wang KY; Chen HM; Lee DJ; Yang SS; Tsai CH; Lien CC; Chern Y
    Mov Disord; 2019 Jun; 34(6):845-857. PubMed ID: 30840784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington's Disease and Its Comorbidities.
    Andrews K; Josiah SS; Zhang J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into GABA
    Hsu YT; Chang YG; Chern Y
    Open Biol; 2018 Dec; 8(12):. PubMed ID: 30518638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Efficacy of the KCC2 Cotransporter Promotes Epileptic Oscillations in a Subiculum Network Model.
    Buchin A; Chizhov A; Huberfeld G; Miles R; Gutkin BS
    J Neurosci; 2016 Nov; 36(46):11619-11633. PubMed ID: 27852771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model.
    Dargaei Z; Bang JY; Mahadevan V; Khademullah CS; Bedard S; Parfitt GM; Kim JC; Woodin MA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1618-E1626. PubMed ID: 29382760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK3 Maintains the GABAergic Inhibitory Tone, Synaptic Excitation and Neuronal Excitability
    Lim WM; Chin EWM; Tang BL; Chen T; Goh ELK
    Front Mol Neurosci; 2021; 14():762142. PubMed ID: 34858138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain.
    Waldvogel HJ; Faull RL
    Adv Pharmacol; 2015; 73():223-64. PubMed ID: 25637443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cation-chloride cotransporters and the polarity of GABA signalling in mouse hippocampal parvalbumin interneurons.
    Otsu Y; Donneger F; Schwartz EJ; Poncer JC
    J Physiol; 2020 May; 598(10):1865-1880. PubMed ID: 32012273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
    Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
    J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter KCC2.
    Medina I; Friedel P; Rivera C; Kahle KT; Kourdougli N; Uvarov P; Pellegrino C
    Front Cell Neurosci; 2014; 8():27. PubMed ID: 24567703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
    Giampà C; Laurenti D; Anzilotti S; Bernardi G; Menniti FS; Fusco FR
    PLoS One; 2010 Oct; 5(10):e13417. PubMed ID: 20976216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175
    Lim SAO; Surmeier DJ
    Front Syst Neurosci; 2020; 14():626412. PubMed ID: 33551760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease.
    Paraskevopoulou F; Parvizi P; Senger G; Tuncbag N; Rosenmund C; Yildirim F
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neto2-null mice have impaired GABAergic inhibition and are susceptible to seizures.
    Mahadevan V; Dargaei Z; Ivakine EA; Hartmann AM; Ng D; Chevrier J; Ormond J; Nothwang HG; McInnes RR; Woodin MA
    Front Cell Neurosci; 2015; 9():368. PubMed ID: 26441539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential GABAergic disinhibition during the development of painful peripheral neuropathy.
    Janssen SP; Truin M; Van Kleef M; Joosten EA
    Neuroscience; 2011 Jun; 184():183-94. PubMed ID: 21496475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.